Exact Mass: 617.2290756
Exact Mass Matches: 617.2290756
Found 97 metabolites which its exact mass value is equals to given mass value 617.2290756
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
N-({(1s,2r)-2-[(S)-[(1r)-1-{[(Benzyloxy)carbonyl]amino}-2-Phenylethyl](Hydroxy)phosphoryl]cyclopentyl}carbonyl)-L-Tryptophan
TROGLITAZONE GLUCURONIDE
Cys Phe Trp Tyr
C32H35N5O6S (617.2307930000001)
Cys Phe Tyr Trp
C32H35N5O6S (617.2307930000001)
Cys Trp Phe Tyr
C32H35N5O6S (617.2307930000001)
Cys Trp Tyr Phe
C32H35N5O6S (617.2307930000001)
Cys Tyr Phe Trp
C32H35N5O6S (617.2307930000001)
Cys Tyr Trp Phe
C32H35N5O6S (617.2307930000001)
Glu Phe His Trp
C31H35N7O7 (617.2597840000001)
Glu Phe Trp His
C31H35N7O7 (617.2597840000001)
Glu His Phe Trp
C31H35N7O7 (617.2597840000001)
Glu His Trp Phe
C31H35N7O7 (617.2597840000001)
Glu Trp Phe His
C31H35N7O7 (617.2597840000001)
Glu Trp His Phe
C31H35N7O7 (617.2597840000001)
Phe Cys Trp Tyr
C32H35N5O6S (617.2307930000001)
Phe Cys Tyr Trp
C32H35N5O6S (617.2307930000001)
Phe Glu His Trp
C31H35N7O7 (617.2597840000001)
Phe Glu Trp His
C31H35N7O7 (617.2597840000001)
Phe His Glu Trp
C31H35N7O7 (617.2597840000001)
Phe His Trp Glu
C31H35N7O7 (617.2597840000001)
Phe Trp Cys Tyr
C32H35N5O6S (617.2307930000001)
Phe Trp Glu His
C31H35N7O7 (617.2597840000001)
Phe Trp His Glu
C31H35N7O7 (617.2597840000001)
Phe Trp Tyr Cys
C32H35N5O6S (617.2307930000001)
Phe Tyr Cys Trp
C32H35N5O6S (617.2307930000001)
Phe Tyr Trp Cys
C32H35N5O6S (617.2307930000001)
His Glu Phe Trp
C31H35N7O7 (617.2597840000001)
His Glu Trp Phe
C31H35N7O7 (617.2597840000001)
His Phe Glu Trp
C31H35N7O7 (617.2597840000001)
His Phe Trp Glu
C31H35N7O7 (617.2597840000001)
His Trp Glu Phe
C31H35N7O7 (617.2597840000001)
His Trp Phe Glu
C31H35N7O7 (617.2597840000001)
Ser Trp Tyr Tyr
Ser Tyr Trp Tyr
Ser Tyr Tyr Trp
Trp Cys Phe Tyr
C32H35N5O6S (617.2307930000001)
Trp Cys Tyr Phe
C32H35N5O6S (617.2307930000001)
Trp Glu Phe His
C31H35N7O7 (617.2597840000001)
Trp Glu His Phe
C31H35N7O7 (617.2597840000001)
Trp Phe Cys Tyr
C32H35N5O6S (617.2307930000001)
Trp Phe Glu His
C31H35N7O7 (617.2597840000001)
Trp Phe His Glu
C31H35N7O7 (617.2597840000001)
Trp Phe Tyr Cys
C32H35N5O6S (617.2307930000001)
Trp His Glu Phe
C31H35N7O7 (617.2597840000001)
Trp His Phe Glu
C31H35N7O7 (617.2597840000001)
Trp Ser Tyr Tyr
Trp Tyr Cys Phe
C32H35N5O6S (617.2307930000001)
Trp Tyr Phe Cys
C32H35N5O6S (617.2307930000001)
Trp Tyr Ser Tyr
Trp Tyr Tyr Ser
Tyr Cys Phe Trp
C32H35N5O6S (617.2307930000001)
Tyr Cys Trp Phe
C32H35N5O6S (617.2307930000001)
Tyr Phe Cys Trp
C32H35N5O6S (617.2307930000001)
Tyr Phe Trp Cys
C32H35N5O6S (617.2307930000001)
Tyr Ser Trp Tyr
Tyr Ser Tyr Trp
Tyr Trp Cys Phe
C32H35N5O6S (617.2307930000001)
Tyr Trp Phe Cys
C32H35N5O6S (617.2307930000001)
Tyr Trp Ser Tyr
Tyr Trp Tyr Ser
Tyr Tyr Ser Trp
Tyr Tyr Trp Ser
LY-2584702 tosylate salt
LY-2584702 tosylate salt is a selective ATP competitive inhibitor of p70S6K with an IC50 of 4 nM. In S6K1 enzyme assay, the IC50 of LY-2584702 is 2 nM.
Fmoc-glu(edans)-OH
N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N2-(2-((5-sulfonaphthalen-1-yl)amino)ethyl)-L-glutamine is a glutamine derivative[1].
Benzeneacetamide, N-((4-hydroxy(1,1-biphenyl)-3-yl)methyl)-3-(2-(((2R)-2-hydroxy-2-(4-hydroxy-3-((methylsulfonyl)amino)phenyl)ethyl)amino)-2-methylpropyl)-
Milademetan
C30H34Cl2FN5O4 (617.1971755999999)
C274 - Antineoplastic Agent > C129839 - Apoptotic Pathway-targeting Antineoplastic Agent > C162996 - MDM2 Inhibitor
[8,12-bis(2-carboxyethyl)-2,17-bis(ethenyl)-3,7,13,18-tetramethyl-23H-porphyrin-21-ium-21-ylidene]iron
2-[[2-[hydroxy-[2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphoryl]cyclopentanecarbonyl]amino]-3-(1H-indol-3-yl)propanoic acid
platensimycin B4 methyl ester
A polycyclic cage that is the methyl ester derivative of platensimycin B4. It is isolated from Streptomyces platensis.
[(4S,5S)-5-(2-azidophenyl)-4-[2-(benzenesulfonyl)ethyl]-2-[4-(3-hydroxypropoxy)phenyl]-5H-oxazol-4-yl]-(1-piperidinyl)methanone
C32H35N5O6S (617.2307930000001)
N-[(4R,7R,8S)-5-[(2,5-difluorophenyl)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-methoxybenzenesulfonamide
C31H37F2N3O6S (617.2371006000001)
(2R,3R,4R,5S,6R)-6-[[2-[[4-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]phenoxy]methyl]-2,5,7,8-tetramethyl-3,4-dihydrochromen-6-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
6-[[2-[[4-[(2,4-Dioxo-1,3-thiazolidin-5-yl)methyl]phenoxy]methyl]-2,5,7,8-tetramethyl-3,4-dihydrochromen-6-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
3-[(5s)-5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl]-n-[2-hydroxy-3-(methoxycarbonyl)-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl]propanimidic acid
3,9,23-trihydroxy-1,5,20-trimethyl-6-(5-oxo-2h-furan-3-yl)-5'h-11,17,19,24-tetraoxaspiro[heptacyclo[12.12.0.0²,¹⁰.0⁵,⁹.0¹⁰,¹².0¹⁶,²⁵.0¹⁸,²³]hexacosane-22,2'-[1,3]thiazol]-4-one
4-[1-(acetyloxy)-2-(5-oxo-2h-furan-3-yl)ethyl]-2-(benzoyloxy)-3-hydroxy-3,4,8,8a-tetramethyl-2,4a,5,6-tetrahydro-1h-naphthalen-1-yl pyridine-3-carboxylate
(1s,3r,5s,7r,9s,10r,12r,14r,15s,18r,19s,22s,23r)-4',10-dihydroxy-22-(hydroxymethyl)-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-5'h-4,6,11-trioxaspiro[hexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-9,2'-[1,3]thiazole]-14-carbaldehyde
C32H43NO9S (617.2658388000001)